BioCentury | Nov 22, 2019
Finance
Syncona backs Cambridge oncology spinout Azeria in £32M series B
...Azeria is the first company in which Syncona has followed an indirect investment via the CRT Pioneer Fund...
...Azeria is the first company in which Syncona has followed an indirect investment via the CRT Pioneer Fund...
...Azeria is the first company in which Syncona has followed an indirect investment via the CRT Pioneer Fund...